Evopoint Biosciences (Exclusive License Agreement)
Funding Details
- Awarder
- RSS - www.prnewswire.com
- Date Award
- May 30, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Company Description
- Evopoint Biosciences is focused on developing innovative antibody-drug conjugates, specifically targeting CLDN18.2, to improve treatment outcomes in cancer patients.
- Market
- Pharmaceuticals
- Location
- USA